MetaCap

Fair Isaac (FICO) vs HealthEquity (HQY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

HealthEquity (HQY) has outperformed Fair Isaac (FICO) over the past year, losing 7.0% versus a loss of 61.2%. Over five years, FICO leads with a +100.9% price change compared with +65.1% for HQY. Fair Isaac is the larger company by market cap ($14.84 billion vs $7.84 billion), about 1.9 times the size.

On valuation, Fair Isaac trades at a lower forward P/E (13.6x vs 17.2x for HealthEquity). Fair Isaac converts more of its revenue into profit, with a net margin of 32.9% versus 16.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FICO-61.17%HQY-7.03%
+10%-30%-71%
Nov 21, 20251 yearNov 20, 2026
FICO+94.21%HQY+54.47%
+594%+265%-64%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FICO versus HQY key metrics
MetricFICOHQY
Share price$694.31$94.75
Market cap$14.84B$7.84B
1-day change+2.46%-2.70%
YTD return-58.93%+3.43%
1-year return-61.17%-7.03%
5-year return+100.89%+65.10%
P/E ratio (TTM)19.1234.21
Forward P/E13.6317.17
EPS (TTM)$36.32$2.77
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.53B$1.31B
Revenue growth (YoY)+27.32%+9.47%
Net income (latest FY)$834.97M$215.20M
Gross margin86.13%69.52%
Operating margin49.93%24.55%
Net margin32.94%16.38%
52-week high$1,858.91$110.26
52-week low$586.05$72.76
Distance from 52-week high-62.65%-14.07%
Analyst consensusbuynone
Avg. price target upside+18.30%+27.36%
Average volume805.56K886.63K
Shares outstanding21.38M82.72M
Employees3,7472,814
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HQY has outperformed FICO by 54.1 percentage points over the past year.
  • HealthEquity trades at a higher earnings multiple (34.2x vs 19.1x trailing P/E).
  • Fair Isaac is more profitable, keeping 32.9 cents of every revenue dollar as net income versus 16.4 cents for HealthEquity.
  • Fair Isaac grew revenue faster in its latest fiscal year (+27.32% vs +9.47%).

About Fair Isaac

FICO stock →

Fair Isaac Corporation provides analytics software in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Scores and Software.

Consumer Discretionary · Business Services · 3,747 employees

About HealthEquity

HQY stock →

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.

Consumer Discretionary · Business Services · 2,814 employees

FICO vs HQY FAQ

Which is bigger, Fair Isaac or HealthEquity?

Fair Isaac (FICO) is larger, with a market capitalization of $14.84B compared with $7.84B for HealthEquity (HQY).

Which stock has performed better over the past year, FICO or HQY?

HQY returned -7.03% over the past 12 months, compared with -61.17% for FICO (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, FICO or HQY?

FICO has the lower trailing P/E at 19.1, versus 34.2 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Fair Isaac and HealthEquity in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons